Updated May. 7, 2013 at 11:05 a.m.

Premium Lock BioCryst reports progress for rare disease drug

Published: 2013-05-07 11:00:00
Updated: 2013-05-07 11:05:07

Print this blog post
BioCryst BioCryst

BioCryst is studying a compound to treat hereditary angiodema, a rare genetic disease. Read more about the company's progress with the compound....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll